Darentang (600329.SH) subsidiary obtains drug registration certificate for loxoprofen sodium patches.

Zhitong Finance APP News, Darentang (600329.SH) issued an announcement that its affiliated branch, Jinyao Darentang Group Co., Ltd. Xinxin Pharmaceutical Factory, recently received the "Drug Registration Certificate" for Loxoprofen Sodium Patches approved and issued by the National Medical Products Administration. The Loxoprofen Sodium Patches use a new hot-melt patch technology and are an upgraded product of Loxoprofen Sodium Gel Patches. They feature being thin and light, comfortable to apply, and strong adhesion, and are used for anti-inflammatory and analgesic treatment of the following diseases and symptoms: osteoarthritis, muscle pain, and swelling or pain caused by trauma.